Innoviva, Inc.INVA stock score: 63/100

$18.41 · +0.05% · Scored Nov 19, 2026

Technical
40
Fundamental
69
News
56

The reading

Innoviva (INVA) scores 63 out of 100, which reads neutral, higher than 86% of Healthcare stocks and 87% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 69, technicals 40.

Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Earnings Growth (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 17 and contrarian oscillators 78 — a split worth reading before trusting the technical total.

News sentiment is neutral at 56; it is shown, not counted in the composite.

Since Aug 23, 2026 the composite has ranged from 54 to 65, and it is up 1 point over the period.

About Innoviva

Innoviva (INVA) is a diversified healthcare company that owns royalty interests, sells hospital medicines and holds stakes in other healthcare companies. Its royalty business receives payments from GSK on global sales of the respiratory medicines RELVAR/BREO ELLIPTA and ANORO ELLIPTA, which treat asthma and chronic obstructive pulmonary disease. Its specialty therapeutics business, Innoviva Specialty Therapeutics, sells critical care and infectious disease drugs to hospitals, including GIAPREZA for septic shock and other forms of low blood pressure, XACDURO for serious Acinetobacter infections and XERAVA for complicated abdominal infections, and it also holds the oral gonorrhea treatment zoliflodacin. It works with partners to sell some products outside the United States. Innoviva also holds strategic investments in healthcare companies, including a large stake in Armata Pharmaceuticals. It earns money from royalties, product sales and, at times, gains on investments.

Innoviva’s respiratory royalties depend on GSK’s competition with AstraZeneca, Boehringer Ingelheim and generic inhalers, while its hospital drugs compete with products from Merck, Pfizer and Shionogi and with older generic treatments. Its edge rests on steady royalty cash flow that funds growth in specialty products and a portfolio of drugs for hard-to-treat hospital infections. Investors who follow INVA stock tend to watch sales growth of GIAPREZA and XACDURO. GSK royalty trends and the launch of zoliflodacin are closely followed. The value of strategic investments, convertible debt and share buybacks are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward INVA’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

69

Pulling it up

  • Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Price target score compares the current stock price to analyst consensus targets.

  • Current assets divided by current liabilities: the ability to pay short-term bills.

Holding it back

38 weighted scorers; 1 had no data today and are left out rather than counted as zero.

Technical · daily

26

Pulling it up

  • Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • Relative Strength Index (14-period) measures momentum by comparing recent gains to losses.

  • Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.

Holding it back

  • Where the price sits between its 52-week low and high.

  • Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • Volume Weighted Average Price (VWAP) shows the average price weighted by volume.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
56

Technical score by timeframe

ChartScoreWeight
Hourly461
Daily263
Weekly322
Monthly542
Quarterly532

Composite score, last 90 days

05010063Aug 23, 2026Nov 19, 2026Aug 23, 2026: 62Aug 24, 2026: 62Aug 25, 2026: 63Aug 26, 2026: 64Aug 27, 2026: 61Aug 28, 2026: 61Aug 29, 2026: 61Aug 30, 2026: 61Aug 31, 2026: 61Sep 1, 2026: 63Sep 2, 2026: 65Sep 3, 2026: 63Sep 4, 2026: 64Sep 5, 2026: 64Sep 6, 2026: 63Sep 7, 2026: 63Sep 8, 2026: 64Sep 9, 2026: 62Sep 10, 2026: 61Sep 11, 2026: 61Sep 12, 2026: 61Sep 13, 2026: 61Sep 14, 2026: 62Sep 15, 2026: 62Sep 16, 2026: 64Sep 17, 2026: 63Sep 18, 2026: 64Sep 19, 2026: 63Sep 20, 2026: 63Sep 21, 2026: 63Sep 22, 2026: 63Sep 23, 2026: 62Sep 24, 2026: 62Sep 25, 2026: 61Sep 26, 2026: 61Sep 27, 2026: 60Sep 28, 2026: 62Sep 29, 2026: 63Sep 30, 2026: 64Oct 1, 2026: 61Oct 2, 2026: 59Oct 3, 2026: 59Oct 4, 2026: 59Oct 5, 2026: 60Oct 6, 2026: 61Oct 7, 2026: 63Oct 8, 2026: 63Oct 9, 2026: 64Oct 10, 2026: 64Oct 11, 2026: 64Oct 12, 2026: 65Oct 13, 2026: 62Oct 14, 2026: 62Oct 15, 2026: 62Oct 16, 2026: 61Oct 17, 2026: 61Oct 18, 2026: 61Oct 19, 2026: 62Oct 20, 2026: 65Oct 21, 2026: 64Oct 22, 2026: 62Oct 23, 2026: 60Oct 24, 2026: 60Oct 25, 2026: 60Oct 26, 2026: 62Oct 27, 2026: 62Oct 28, 2026: 63Oct 29, 2026: 65Oct 30, 2026: 64Nov 1, 2026: 64Nov 2, 2026: 64Nov 3, 2026: 62Nov 4, 2026: 62Nov 5, 2026: 56Nov 6, 2026: 54Nov 7, 2026: 54Nov 8, 2026: 54Nov 10, 2026: 56Nov 11, 2026: 54Nov 12, 2026: 64Nov 13, 2026: 64Nov 14, 2026: 64Nov 15, 2026: 64Nov 16, 2026: 63Nov 17, 2026: 63Nov 18, 2026: 63Nov 19, 2026: 63
Show the daily numbers
DateComposite
Nov 19, 202663
Nov 18, 202663
Nov 17, 202663
Nov 16, 202663
Nov 15, 202664
Nov 14, 202664
Nov 13, 202664
Nov 12, 202664
Nov 11, 202654
Nov 10, 202656
Nov 8, 202654
Nov 7, 202654
Nov 6, 202654
Nov 5, 202656
Nov 4, 202662
Nov 3, 202662
Nov 2, 202664
Nov 1, 202664
Oct 30, 202664
Oct 29, 202665
Oct 28, 202663
Oct 27, 202662
Oct 26, 202662
Oct 25, 202660
Oct 24, 202660
Oct 23, 202660
Oct 22, 202662
Oct 21, 202664
Oct 20, 202665
Oct 19, 202662
Oct 18, 202661
Oct 17, 202661
Oct 16, 202661
Oct 15, 202662
Oct 14, 202662
Oct 13, 202662
Oct 12, 202665
Oct 11, 202664
Oct 10, 202664
Oct 9, 202664
Oct 8, 202663
Oct 7, 202663
Oct 6, 202661
Oct 5, 202660
Oct 4, 202659
Oct 3, 202659
Oct 2, 202659
Oct 1, 202661
Sep 30, 202664
Sep 29, 202663
Sep 28, 202662
Sep 27, 202660
Sep 26, 202661
Sep 25, 202661
Sep 24, 202662
Sep 23, 202662
Sep 22, 202663
Sep 21, 202663
Sep 20, 202663
Sep 19, 202663
Sep 18, 202664
Sep 17, 202663
Sep 16, 202664
Sep 15, 202662
Sep 14, 202662
Sep 13, 202661
Sep 12, 202661
Sep 11, 202661
Sep 10, 202661
Sep 9, 202662
Sep 8, 202664
Sep 7, 202663
Sep 6, 202663
Sep 5, 202664
Sep 4, 202664
Sep 3, 202663
Sep 2, 202665
Sep 1, 202663
Aug 31, 202661
Aug 30, 202661
Aug 29, 202661
Aug 28, 202661
Aug 27, 202661
Aug 26, 202664
Aug 25, 202663
Aug 24, 202662
Aug 23, 202662

Key facts

Market cap
$1.3B
Sector
Healthcare
Industry
Biotechnology
Beta
0.37
Risk grade (1–10)
6
Next earnings
Nov 4, 2026

Questions

What is INVA's stock rating today?

INVA scores 63/100 (Neutral) as of Nov 19, 2026: technical 40, fundamental 69, and news sentiment 56, which is shown but not counted. Scores are recomputed every night.

What does Innoviva do?

Innoviva (INVA) is a diversified healthcare company that owns royalty interests, sells hospital medicines and holds stakes in other healthcare companies. Its royalty business receives payments from GSK on global sales of the respiratory medicines RELVAR/BREO ELLIPTA and ANORO ELLIPTA, which treat asthma and chronic obstructive pulmonary disease.

Is INVA stock a buy?

The score is not a buy or sell recommendation. A 63 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the INVA score calculated?

100 weighted scorers feed it today: 38 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

INVA stock score

HTML

<a href="https://stocksscores.com/stocks/inva/"><img src="https://stocksscores.com/stocks/inva/badge.svg" alt="INVA stock score" height="20"></a>

Markdown

[![INVA stock score](https://stocksscores.com/stocks/inva/badge.svg)](https://stocksscores.com/stocks/inva/)